Related Experiment Videos
An in vitro bovine pericardial hemocompatibility testing system
1Baxter Healthcare Edwards CVS Division, Irvine, CA, USA.
The Journal of Heart Valve Disease
|July 4, 1998
Summary
This study developed an in vitro system to test bovine pericardial tissue hemocompatibility. Glutaraldehyde-fixed tissue showed more fibrinogen binding but less kallikrein activation than non-fixed tissue.
Area of Science:
- Biomaterials Science
- Biomedical Engineering
- Cardiovascular Research
Background:
- Bovine pericardium is a common biomaterial for heart valves, used since the 1960s.
- Cross-linking agents like glutaraldehyde are used to improve durability and reduce immune response.
- Evaluating improvements in bovine pericardial valve performance requires reliable in vitro test systems.
Purpose of the Study:
- To describe and validate an in vitro test system for evaluating pericardial tissue hemocompatibility.
- To assess the effects of glutaraldehyde fixation on blood-tissue interactions.
Main Methods:
- Non-fixed and glutaraldehyde-fixed (GA) bovine pericardial tissues were exposed to whole blood.
- Analyzed plasma for kallikrein activation and platelet factor 4 (PF4) release.
- Assessed tissue for fibrinogen binding and cellular response using scanning electron microscopy.
Main Results:
- Established optimal conditions for the in vitro test system, including a 60-minute blood exposure time.
- Non-fixed tissue showed greater kallikrein activation and PF4 release.
- GA-treated tissue exhibited higher fibrinogen binding and a different cellular response pattern.
Conclusions:
- The developed non-static in vitro system shows promise for routine hemocompatibility testing of blood-contacting biomaterials.
- Glutaraldehyde fixation significantly alters the hemocompatibility profile of bovine pericardium.